Ponce Therapeutic’s (“Ponce”) lead product, ReBeaut™, is a microneedle patch containing nanoparticles carrying its proprietary ApoptiCIDe™ cell elimination gene therapy technology targeting senescent keratinocytes and fibroblasts in the skin Speratum Biopharma (“Speratum”)…
Company applying novel, high-throughput screening technologies to DELIVER therapeutics that address the most difficult problems in clinical medicine Rapha Capital BioVentures Fund I Leads Convertible Note Financing to initiate operations MIAMI, Dec. 14, 2021 /PRNewswire/ — DELIVER…
3DBio Therapeutics, a biotech company in Queens, said it had for the first time used 3-D printing to make a body part with a patent’s own cells. View Full New…